Wednesday
SESSION 30: CLI AND THE ANGIOSOME CONCEPT; REOPERATIONS AND REINTERVENTION; OTHER NEW CONCEPTS AND TECHNIQUES
SESSION 30 SCHEDULE
4:39 PM - 4:44 PM DEBATE: The Angiosome Concept Has Been Proven Helpful With Open Surgical And Endovascular Treatments Of CLI With Gangrenous Or Ulcerated Lesions
  Presenter(s):Richard F. Neville, MD  
  View Slides in PDF      
4:45 PM - 4:50 PM DEBATE: The Angiosome Concept Has Not Been Proven Helpful In The Treatment Of CLI With Gangrenous Or Ulcerated Lesions
  Presenter(s):Bauer E. Sumpio, MD, PhD  
  View Slides in PDF      
4:51 PM - 4:56 PM Angiosome Targeted Revascularization Is More Important With Endovascular Repair Than Bypass Surgery
  Presenter(s):Maarit Venermo, MD, PhD  
  View Slides in PDF      
4:57 PM - 5:02 PM Critique Of The Angiosome Concept: It Is Not Simple: Outcomes Depend More On The Distribution System In The Foot Than Angiosomes
  Presenter(s):Roberto Ferraresi, MD  
  View Slides in PDF      
5:03 PM - 5:08 PM Is The Angiosome Concept Worthwhile And How Should It Be Used
  Presenter(s):Peter A. Schneider, MD  
  View Slides in PDF      
5:09 PM - 5:14 PM Update On The Angiosome Concept: Itís Not All Itís Cracked Up To Be: What Other Factors Are More Important
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
  View Slides in PDF      
5:15 PM - 5:20 PM The Angiosome Concept Is Not Necessary To Achieve Limb Salvage With Ischemic Gangrenous Foot Lesions
  Presenter(s):Ignacio Escotto, MD  
  View Slides in PDF      
5:21 PM - 5:26 PM Angiosomes Of The Foot Have Tremendous Variability As Indicated By Laser-Assisted Indocyanine Green Imaging Using The SPY SYSTEM
  Presenter(s):Werner Lang, MD  
  View Slides in PDF      
5:27 PM - 5:32 PM The Importance Of Reoperation Or Reintervention When A Primary Procedure For CLI Fails And The Limb Is Rethreatened: 1, 2, 3, 4 And More Procedures Can Be Worthwhile: A Vascular Surgeonís View
  Presenter(s):Evan C. Lipsitz, MD  
  View Slides in PDF      
NEW CONCEPTS AND TECHNIQUES
5:33 PM - 5:38 PM Vorapaxar - A New PAR-1 Receptor Blocker, Improves Cardiovascular And Limb Outcomes In PAD Patients: The FDA Agrees
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
  View Slides in PDF      
5:39 PM - 5:44 PM When And How Should Distal Embolic Protection Devices Be Used With Lower Extremity Interventions
  Presenter(s):D. Christopher Metzger, MD   
  View Slides in PDF      
5:45 PM - 5:55 PM Panel Discussion

End of Program D

END OF SESSION 30
previous next